Download Library



Download Library
Document Type
Cemiplimab Phase 3 Cervical Cancer Poster
A Study of REGN3767, an Anti-LAG-3 Antibody, Alone and in Combination with Cemiplimab (REGN2810), an Anti-PD1 Antibody, in Advanced Cancers
Financial Overview 2018
Financial Overview 2017
2018 Cemiplimab Illustrative Example
Financial Overview 2016
Financial Overview 2015
Dupilumab - Type 2 Biomarkers - Phase 3 Study LIBERTY ASTHMA QUEST
Dupilumab - Rapid and Sustained Improvements in FEV1 LIBERTY ASTHMA QUEST Study
Dupilumab - Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms - LIBERTY ASTHMA QUEST Study
= add file to Briefcase